Tammy Lovell

NHSX, health inequalities, AI, NHS AI Lab
By  Tammy Lovell 02:20 am October 25, 2021
The funding is part of the AI Ethics Initiative at NHSX in the UK.
Medical Device Coordination Group, European Union, Vodafone, Deloitte, IMS Maxims, MRI, Alnylam Pharmaceuticals
By  Tammy Lovell 06:08 am October 22, 2021
Also, new guidance published on classification of medical devices in the EU.
ORCHA, COVID-19, health apps, NHS, physiotherapy
By  Tammy Lovell 10:47 am October 20, 2021
ORCHA study found musculoskeletal and physiotherapy apps were most popular.
Top Doctors, Series B Funding, Impact Partners, ICF Venture Tech II
By  Tammy Lovell 09:44 am October 18, 2021
The investment will support further growth in key markets.
Research2Guidance, patient data, clinical trials, apps
By  Tammy Lovell 05:39 am October 18, 2021
The market is forecast to reach $9.13 billion (€7.84 billion) by 2026.
Big Health, NHS Scotland, Sleepio, Daylight, digital therapeutics, cCBT, mental health
By  Tammy Lovell 12:02 pm October 13, 2021
More than five million adults will be able to access to CBT through Big Health’s apps.
Babylon, funding
By  Tammy Lovell 03:53 pm October 12, 2021
 The deal will provide guaranteed capital to fuel the firm’s rapid growth plan.
Stress Point Health, mental health, SPHERE, meditation, neurofeedback
By  Tammy Lovell 02:37 am October 11, 2021
A study by Imperial College London found the therapy was more effective in treating stress, anxiety and PTSD than popular meditation apps.
Juno, CQC, privacy, data governance, Forward Clinical
By  Tammy Lovell 02:22 am October 11, 2021
The regulator’s report flagged governance issues in the midwifery and pediatrics service. 
Habitual, seed funding, Atlantic Food Labs, Oxford Seed Fund, diabetes management, type 2 diabetes
By  Tammy Lovell 07:35 am October 8, 2021
The firm provides a food replacement and digital support programme for people living with type 2 diabetes.